Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-08-07Clinical Trial Update: Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors [Phase 2]
Phase 2 clinical trial investigating mechanisms of weight loss maintenance with SGLT2 inhibitors has been withdrawn. The study was sponsored…
-
CLINICAL_TRIALS withdrawal · 2024-07-10Clinical Trial Update: Dexamethasone/Pancreatic Clamp P&F [Phase 1]
The Phase 1 trial evaluating a dexamethasone-based pancreatic clamp for insulin resistance, prediabetes, NAFLD, and obesity has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Strategies to Promote Physical Activity [NA]
A Stanford University-sponsored trial on strategies to promote physical activity for obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans [Phase 2]
This report notes that a Phase 2 trial investigating novel estrogens for effects on glucose and lipid measures in postmenopausal prediabetic…
-
CLINICAL_TRIALS withdrawal · 2023-11-03Clinical Trial Update: Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients [Phase 3]
A Phase 3 trial evaluating semaglutide for reducing arrhythmia burden in overweight patients with atrial fibrillation has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-11-14Clinical Trial Update: Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity [Phase 3]
A Phase 3 clinical trial comparing semaglutide tablets with empagliflozin tablets for type 2 diabetes and obesity was withdrawn.
-
EMA withdrawal · 2022-10-28EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
EMA confirms a recommendation to withdraw marketing authorisations for amfepramone medicines used for weight loss due to safety concerns.
-
CLINICAL_TRIALS withdrawal · 2022-05-06Clinical Trial Update: TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia [Phase 4]
Phase 4 trial comparing morphine vs PCA IV hydromorphone for post-cesarean analgesia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-01Clinical Trial Update: Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery [Phase 4]
A Phase 4 clinical trial evaluating naltrexone/bupropion (Mysimba) for weight outcomes after obesity surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-09-21Clinical Trial Update: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat [Phase 4]
A Phase 4 trial investigating antigen-lipid–driven monoclonal gammopathies targeting epicardial fat has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-31Clinical Trial Update: Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program [Phase 3]
A Phase 3 clinical trial evaluating a high viscosity dietary fibre within a medically supervised weight management program for obesity was w…
-
CLINICAL_TRIALS withdrawal · 2019-04-18Clinical Trial Update: Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery [Phase 4]
A Phase 4 study investigating sphenopalatine ganglion block to prevent shoulder pain after laparoscopic bariatric surgery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: Return on Investment on Lap Gastric Bypass Regarding Quality of Life
A clinical trial evaluating laparoscopic gastric bypass and its effect on quality of life for obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Neujia Anastomosis for Treatment of Obesity and Type II Diabetes [NA]
A clinical trial (NCT03675074) assessing Neujia Anastomosis for obesity and Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors [NA]
A clinical trial evaluating a web-based lifestyle modification program for obese patients with cardiovascular risk factors has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess [EARLY_Phase 1]
An early phase 1 trial studying short-term adrenal suppression to reduce androgen overproduction in overweight girls with androgen excess ha…
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction [EARLY_Phase 1]
A Phase EARLY_PHASE1 trial evaluating longer-term adrenal suppression with low-dose hydrocortisone to reduce androgen overproduction has bee…
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess [EARLY_Phase 1]
EARLY_PHASE1 clinical trial evaluating short-term ovarian suppression to reduce androgen overproduction in overweight girls with androgen ex…
-
CLINICAL_TRIALS withdrawal · 2018-06-12Clinical Trial Update: Leak Pressure After Reinforcement in Gastric Specimens [NA]
A clinical trial on leak pressure after reinforcement in gastric specimens for obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: Feasibility of Use of BariCare App in Pre-transplant Population [NA]
A Mayo Clinic trial evaluating the BariCare app feasibility in obesity patients awaiting kidney or liver transplantation was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-14Clinical Trial Update: Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment (Part 2) [NA]
A clinical trial studying the emotional and cognitive factors in a behavioral weight loss program has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-06Clinical Trial Update: Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients [Phase 4]
A Phase 4 clinical trial evaluating perioperative cefazolin for surgical antibiotic prophylaxis in obese patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-06Clinical Trial Update: Natriuretic Peptides and Metabolic Risk in Obesity [EARLY_Phase 1]
EARLY_PHASE1 trial evaluating natriuretic peptides for metabolic risk in obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-16Clinical Trial Update: RELIEF Europe Study [NA]
The RELIEF Europe Study, sponsored by Torax Medical, evaluating GERD and obesity-related conditions, has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-08-31Clinical Trial Update: Transoral Gastric Volume Reduction as an Intervention for Weight Management [NA]
Clinical trial NCT02578836 on Transoral Gastric Volume Reduction for weight management has been withdrawn.